Form 4: Baxter International EVP, Chief HR Officer Jeanne K. Mason Reports Equity Grant

Jeanne K. Mason, EVP and Chief HR Officer of Baxter International, reports the acquisition of restricted stock units (RSUs) as part of her annual equity grant.

Summary

• Jeanne K. Mason, an executive at Baxter International Inc., filed a Form 4 on March 8, 2024, reporting a transaction that occurred on March 6, 2024.
• The transaction involved the acquisition of 47,630 shares of Baxter's common stock, valued at $0, through an equity grant.
• These shares are in the form of restricted stock units (RSUs) that will vest in three equal annual installments starting on March 6, 2025.
• Following the reported transaction, Mason directly owns 188,481 shares of Baxter's common stock.
• Mason has also granted power of attorney to David S. Rosenbloom, Ellen K. Bradford, and Kimberly Olson to execute and file Forms 4, 5, and 144 on her behalf.

Sentiment

Score: 7

Explanation: The document reflects a routine executive compensation practice, indicating stability and alignment of interests. The sentiment is neutral to slightly positive.

Positives

• The equity grant aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The RSUs will vest in three equal annual installments beginning on March 6, 2025, subject to continued employment.

Industry Context

Equity grants are a common practice in the pharmaceutical and medical device industry to incentivize and retain key executives. These grants align executive compensation with company performance and shareholder value.

Comparison to Industry Standards

• Companies like Medtronic, Johnson & Johnson, and Abbott also use equity grants as part of their executive compensation packages.
• The vesting schedules and grant sizes are typically benchmarked against peer companies to ensure competitiveness.
• The specific terms of the RSU grant, such as the vesting schedule and performance conditions, are likely determined based on industry best practices and Baxter's compensation philosophy.

Stakeholder Impact

• Shareholders: The equity grant aligns executive interests with shareholder value.
• Employees: The grant is part of the company's overall compensation strategy.
• Executive: The grant provides additional compensation and incentives for performance.

Key Dates